Cargando…
m6A RNA Methylation in Systemic Autoimmune Diseases—A New Target for Epigenetic-Based Therapy?
The general background of autoimmune diseases is a combination of genetic, epigenetic and environmental factors, that lead to defective immune reactions. This erroneous immune cell activation results in an excessive production of autoantibodies and prolonged inflammation. During recent years epigene...
Autor principal: | Wardowska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001529/ https://www.ncbi.nlm.nih.gov/pubmed/33807762 http://dx.doi.org/10.3390/ph14030218 |
Ejemplares similares
-
M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics
por: Huang, Yurong, et al.
Publicado: (2023) -
The role of m(6)A RNA methylation in autoimmune diseases: Novel therapeutic opportunities
por: Shan, Yunan, et al.
Publicado: (2023) -
Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
por: Radic, Marko, et al.
Publicado: (2013) -
Exploration of m(6)A methylation regulators as epigenetic targets for immunotherapy in advanced sepsis
por: Qian, Weiwei, et al.
Publicado: (2023) -
The crosstalk between m(6)A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling
por: Zhao, Yanchun, et al.
Publicado: (2021)